Compounds > fluorodopa f 18
Page last updated: 2024-08-24

fluorodopa f 18 and Neuroblastoma

fluorodopa f 18 has been researched along with Neuroblastoma in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabria, M; Cistaro, A; Conte, M; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G1
Conte, M; Foppiani, L; Lopci, E; Morana, G; Piccardo, A1
Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G1
Chiu, CH; Huang, YY; Liu, CC; Liu, YL; Shiue, CY; Tang, KH; Tsai, CL; Tzen, KY; Wen, HP1
de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M1
Chang, HH; Hsu, WM; Huang, SF; Jeng, YM; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, CC; Lu, MY; Miser, JS; Tzen, KY; Yang, YL1
Chang, HH; Hsu, WM; Jou, ST; Ko, CL; Ko, KY; Liu, CJ; Liu, YL; Lu, MY; Tzen, KY; Yang, YL; Yen, RF1
Capriati, V; Dimiccoli, V; Mandracchia, D; Maqoud, F; Mele, A; Scilimati, A; Tolomeo, A; Trapani, A; Trapani, G; Tricarico, D; Vitale, P1
Altrinetti, V; Bianchi, P; Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G1
Altrinetti, V; Chiti, A; Cistaro, A; Fanti, S; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Villavecchia, G1
Chiti, A; D'Ambrosio, D; Fanti, S; Lopci, E; Marengo, M; Nanni, C; Pession, A1
Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL1

Trials

2 trial(s) available for fluorodopa f 18 and Neuroblastoma

ArticleYear
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:4

    Topics: Child; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neuroblastoma; Neuroendocrine Tumors; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed

2012
Feasibility of carbidopa premedication in pediatric patients: a pilot study.
    Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:10

    Topics: Carbidopa; Child; Child, Preschool; Dihydroxyphenylalanine; Drug Interactions; Female; Fluorine Radioisotopes; Humans; Male; Neuroblastoma; Pilot Projects; Premedication; Radionuclide Imaging; Radiopharmaceuticals

2012

Other Studies

10 other study(ies) available for fluorodopa f 18 and Neuroblastoma

ArticleYear
Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:1

    Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Dihydroxyphenylalanine; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Tomography, X-Ray Computed

2014
(18)F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma.
    Pediatric radiology, 2014, Volume: 44, Issue:3

    Topics: Bone Marrow Neoplasms; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Induction Chemotherapy; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome

2014
Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6

    Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Thoracic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2014
Impact of residual (18)F-fluoride in (18)F-FDOPA for the diagnosis of neuroblastoma.
    Annals of nuclear medicine, 2015, Volume: 29, Issue:6

    Topics: Bone Neoplasms; Child; Child, Preschool; Chromatography; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Infant; Male; Multimodal Imaging; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging

2015
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:12

    Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals

2015
Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
    Oncotarget, 2016, Apr-05, Volume: 7, Issue:14

    Topics: Cohort Studies; Dihydroxyphenylalanine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genomics; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome

2016
Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphatic Metastasis; Male; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017
A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease.
    International journal of pharmaceutics, 2017, Mar-15, Volume: 519, Issue:1-2

    Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Neuroblastoma; Neuroendocrine Tumors; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar

2017
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Infant; Male; Multimodal Imaging; Neoplasm Staging; Neuroblastoma; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed

2012
Characterization of neuroblastic tumors using 18F-FDOPA PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:1

    Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid

2013